ArticleFrontiers in medicine2026
Correction: Efficacy and safety of IL-23 inhibitors in the treatment of moderate to severe ulcerative colitis: a meta-analysis based on randomized controlled trials.
Minyang He et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.